Drugs for lipid management

Authors: Lars A Carlson

Publish Date: 2011

Volume: , Issue: , Pages: 89-113

PDF Link

Abstract

The discovery of statins and the early groundbreaking clinical results with statins are described above in Chapter 8 The efficacy of statins to reduce new events of clinical atherosclerosis in primary as well as secondary prevention is evident from an extensive almost overwhelming literature on the subject There is no doubt that patients at risk for clinical atherosclerosis irrespective of lipid risk factors will benefit from statins as firstline treatment however it may well have to be combined with other Lipid management drugs depending on the type of dyslipidaemia and the response to statins It is worth noting that there is a residual risk after treatment with statins of clinical atherosclerosis events that varies between 40–60

Keywords: